Erratum to: Xeno-repopulation of Fah -/- Nod/Scid mice livers by human hepatocytes (SCIENCE CHINA Life Sciences, (2011), 54, 3 (227-234), 10.1007/s11427-011-4140-7);Xeno-repopulation of Fah-/-Nod/Scid mice livers by human hepatocytes

Science China Life Sciences

Volumn 54, Issue 3, 2011, Pages 227-234

  Su, Bao Liang ^a,b   Liu, Chang Cheng ^a   Xiang, Dao ^a   Zhang, Hai Bin ^a   Yuan, Si Ming ^c   Wang, Min Jun ^a   Chen, Fei ^a   Zhu, Hai Ying ^a   He, Zhi Ying ^a   Wang, Xin ^d   Hu, YiPing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

cell transplantation; Fah gene knockout mice; human hepatocyte; humanized liver; Nod Scid mice

Indexed keywords

ANIMALIA; MUS;

EID: 79952855308     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4185-7     Document Type: Erratum

References (22)

1. Meuleman P, Libbrecht L, De Vos R, et al. Morphological and biochemical characterization of a human liver in an uPA-SCID mouse chimera. Hepatology, 2005, 41: 847-856.
2. Dandri M, Burda M R, Török E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology, 2001, 33: 981-988.
3. Mercer D F, Schiller D E, Elliott J F, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med, 2001, 7: 927-933.
4. Vanwolleghem T, Bukh J, Meuleman P, et al. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain. Hepatology, 2008, 47: 1846-1855.
5. Sugiyama M, Tanaka Y, Kurbanov F, et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology, 2009, 136: 652-662.
6. Dandri M, Murray J M, Lutgehetmann M, et al. Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia. Hepatology, 2008, 48: 1079-1086.
7. -/- mice. Nat Biotechnol, 2007, 25: 903-910.
8. Bissig K D, Le T T, Woods N B, et al. Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model. Proc Natl Acad Sci USA, 2007, 104: 20507-20511.
9. -/- mice after pharmacological immunosuppression. Am J Pathol, 2010, 177: 1311-1319.
10. Grompe M, al-Dhalimy M, Finegold M, et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev, 1993, 12: 2298-2307.
11. Overturf K, al-Dhalimy M, Ou C N, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol, 1997, 151: 1273-1280.
12. Wang X, Montini E, Al-Dhalimy M, et al. Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol, 2002, 161: 565-574.
13. Wang X, Foster M, Al-Dhalimy M, et al. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci USA, 2003, 100: 11881-11888.
14. Shultz L D, Schweitzer P A, Christianson S W, et al. Multiple defects of innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol, 1995, 154: 180-191.
15. Wilber A, Wangensteen K J, Chen Y, et al. Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther, 2007, 15: 1280-1287.
16. Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol, 2004, 165: 901-912.
17. Rhim J A, Sandgren E P, Degen J L, et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science, 1994, 263: 1149-1152.
18. Escribano O, Fernández-Moreno M D, Piña M J, et al. Pretreatment with FK506 up-regulates insulin receptors in regenerating rat liver. Hepatology, 2002, 36: 555-561.
19. Kawamura I, Takeshita S, Fushimi M, et al. Induction of choleresis by inmunosuppressant FK506 through stimulation of insulin-like growth factor I production in the liver of rats. Eur J Pharmacol, 2001, 419: 99-105.
20. Tanaka N, Yamamoto H, Tatemoto A, et al. Regulation of liver regeneration by interleukin-2 and its inhibitors: Cyclosporin A and FK506. Int J Immunopharmacol, 1993, 15: 211-218.
21. Thomale U W, Bender M, Casalis P, et al. Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats. Immunobiology, 2007, 212: 567-576.
22. Setkowicz Z, Caryk M, Szafraniec M, et al. Tacrolimus (FK506) and cyclosporin A reduce macrophage recruitment to the rat brain injured at perinatal and early postnatal periods. Neurol Res, 2009, 31: 1060-1067.